Erick R. Solis

Array ( [id] => 1589029 [patent_doc_number] => RE037936 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Pesticidal 1-polyarylpyrazoles' [patent_app_type] => E1 [patent_app_number] => 09/903990 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11196 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/037/RE037936.pdf [firstpage_image] =>[orig_patent_app_number] => 09903990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543093 [patent_doc_number] => 06372739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Compounds and methods for modulation of estrogen receptors' [patent_app_type] => B1 [patent_app_number] => 09/897048 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11186 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372739.pdf [firstpage_image] =>[orig_patent_app_number] => 09897048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889175 [patent_doc_number] => 20020013315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Gamma secretase inhibitors' [patent_app_type] => new [patent_app_number] => 09/896296 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2701 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013315.pdf [firstpage_image] =>[orig_patent_app_number] => 09896296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327436 [patent_doc_number] => 06329415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Aromatic heterocyclic compounds as antiinflammatory agents' [patent_app_type] => 1 [patent_app_number] => 9/891579 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329415.pdf [firstpage_image] =>[orig_patent_app_number] => 891579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460142 [patent_doc_number] => 06391906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-21 [patent_title] => 'Crystals of celecoxib' [patent_app_type] => B2 [patent_app_number] => 09/887354 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2380 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391906.pdf [firstpage_image] =>[orig_patent_app_number] => 09887354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460631 [patent_doc_number] => 06392039 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Method for preparing (R)-()-3 1-2-(4-benzoyl-2(3, 4-difluorophenyl)morpholin-2-yl)ethyl-4-phenylpiperidin-4-yl-1,1-dimethylurea, its salts solvates and/or hydrates' [patent_app_type] => B1 [patent_app_number] => 09/868562 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5379 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392039.pdf [firstpage_image] =>[orig_patent_app_number] => 09868562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6361759 [patent_doc_number] => 20020058678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Aromatic heterocyclic compounds as antiinflammatory agents' [patent_app_type] => new [patent_app_number] => 09/879776 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19958 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058678.pdf [firstpage_image] =>[orig_patent_app_number] => 09879776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640017 [patent_doc_number] => 06395898 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Trans-glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy-3-(4-fluorophenyl)-1,4-oxazine' [patent_app_type] => B1 [patent_app_number] => 09/878043 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5213 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395898.pdf [firstpage_image] =>[orig_patent_app_number] => 09878043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1270856 [patent_doc_number] => 06653307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-11-25 [patent_title] => '1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents' [patent_app_type] => B2 [patent_app_number] => 09/875432 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22170 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653307.pdf [firstpage_image] =>[orig_patent_app_number] => 09875432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523881 [patent_doc_number] => 06352959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Thiochromanoylpyrazolone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/857053 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29474 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1919 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352959.pdf [firstpage_image] =>[orig_patent_app_number] => 09857053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337797 [patent_doc_number] => 06333325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Method of treating cytokine mediated diseases or conditions' [patent_app_type] => 1 [patent_app_number] => 9/871559 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20060 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1558 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333325.pdf [firstpage_image] =>[orig_patent_app_number] => 871559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243037 [patent_doc_number] => 20020045581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Method for reducing or preventing the establishment, growth or metastasis of cancer by administering PAR-1 and optionally PAR-2 antagonists' [patent_app_type] => new [patent_app_number] => 09/865869 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17525 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045581.pdf [firstpage_image] =>[orig_patent_app_number] => 09865869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079071 [patent_doc_number] => 20010041700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Novel succinate derivative compounds useful as cysteine protease inhibitors' [patent_app_type] => new [patent_app_number] => 09/862674 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43976 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041700.pdf [firstpage_image] =>[orig_patent_app_number] => 09862674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460690 [patent_doc_number] => 06392058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Method for producing 1-substituted 5-Hydroxypyrazoles' [patent_app_type] => B1 [patent_app_number] => 09/856201 [patent_app_country] => US [patent_app_date] => 2001-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392058.pdf [firstpage_image] =>[orig_patent_app_number] => 09856201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477964 [patent_doc_number] => 06344455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'N-4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl-acrylamide, and irreversible inhibitor of tyrosine kinases' [patent_app_type] => B1 [patent_app_number] => 09/831991 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8597 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344455.pdf [firstpage_image] =>[orig_patent_app_number] => 09831991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248751 [patent_doc_number] => 06673923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Pyrazole antimicrobial agents' [patent_app_type] => B2 [patent_app_number] => 09/847962 [patent_app_country] => US [patent_app_date] => 2001-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12553 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 293 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673923.pdf [firstpage_image] =>[orig_patent_app_number] => 09847962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419831 [patent_doc_number] => 06506708 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => '3-(heterocyclyl)-benzoylpyrazole-derivatives' [patent_app_type] => B1 [patent_app_number] => 09/857034 [patent_app_country] => US [patent_app_date] => 2001-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14852 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506708.pdf [firstpage_image] =>[orig_patent_app_number] => 09857034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575477 [patent_doc_number] => 06469076 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Chromene compounds' [patent_app_type] => B1 [patent_app_number] => 09/744305 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11053 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 342 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469076.pdf [firstpage_image] =>[orig_patent_app_number] => 09744305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645432 [patent_doc_number] => 06472538 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Method for producing 1-substituted 5-hydroxypyrazoles' [patent_app_type] => B1 [patent_app_number] => 09/830350 [patent_app_country] => US [patent_app_date] => 2001-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5146 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472538.pdf [firstpage_image] =>[orig_patent_app_number] => 09830350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475649 [patent_doc_number] => 06388071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-14 [patent_title] => 'Alkynyl phenyl heteroaromatic glucokinase activators' [patent_app_type] => B2 [patent_app_number] => 09/841983 [patent_app_country] => US [patent_app_date] => 2001-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14164 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388071.pdf [firstpage_image] =>[orig_patent_app_number] => 09841983 [rel_patent_id] =>[rel_patent_doc_number] =>)